Search
Now showing items 111-114 of 114
HLA Class I and Pediatric HIV disease progression in Botswana and Uganda
(Makerere University, 2023)
Sub-Saharan Africa remains the global epicenter of the HIV epidemic; more than 70% (25 million) of all people living with HIV/AIDS are in Africa. To end the global epidemic, finding an effective HIV vaccine remains a top ...
Risk factors associated with sustained neurocognitive impairment among cryptococcal meningitis survivors; a retrospective analysis at two tertiary hospitals in Uganda
(Makerere University, 2023)
Background: Despite major progress in HIV therapy and management, cryptococcal meningitis (Mbonigaba et al.) remains an important cause of morbidity and mortality among people living with HIV (PLWHIV) in Uganda, including ...
Factors associated with virological non-suppression among adult HIV clients with low-level viremia in Kampala, Uganda
(Makerere University, 2022)
The goal of antiretroviral therapy is to maximize the inhibition of infectious virion production to below the level of detection of less than 50 copies/ml. Clients with LLV have not been fully studied in Uganda and ...
Retention in care, viral suppression and factors associated with viral non-suppression among refugee adolescents infected with HIV at Kyangwali Refugee Settlement in Kikuube District, Uganda
(Makerere University, 2023)
Introduction: Compared to HIV positive non-refugee adolescents, refugee adolescents are generally less likely to receive antiretroviral therapy, and access to the drugs is often inconsistent (UNHCR, 2015). This study aimed ...